D-0245-2015 Class II Terminated

Recalled by Fougera Pharmaceuticals Inc. — Melville, NY

FDA drug recall D-0245-2015 was initiated by Fougera Pharmaceuticals Inc. on Aug 28, 2014 and is designated Class II. Reason for recall: Failed Stability Specifications: The lots of Fluocinonide Gel USP, 0.05% recalled, may not meet the requirements for residual solvents as outlined in USP <467>. The recall status is terminated (terminated Jun 21, 2016). Affected quantity: a) 59,622 Tubes; b) 43,178 Tubes.

Recall details

Product Type
Drugs
Report Date
Nov 19, 2014
Initiation Date
Aug 28, 2014
Termination Date
Jun 21, 2016
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
a) 59,622 Tubes; b) 43,178 Tubes

Product description

FLUOCINONIDE GEL USP, 0.05%, Rx only, For External Use Only, Not For Ophthalmic Use, a) NET WT 15 gram tubes and b) NET WT 60 grams tubes, E. FOUGERA & CO., A division of Fougera Pharmaceuticals Inc., Melville, New York 11747, NDC 0168-0135-15 (15 g) and NDC 0168-0135-60 (60 g)

Reason for recall

Failed Stability Specifications: The lots of Fluocinonide Gel USP, 0.05% recalled, may not meet the requirements for residual solvents as outlined in USP <467>.

Distribution pattern

Nationwide and Puerto Rico

Code information

a) 15 gram lot numbers: 549N, 550N,551N Exp. 1/2015, EB1961, Exp. 2/2017; b) 60 gram lot numbers: 546N, 547N, 548N, Exp. 1/2015, EB0144, Exp. 2/2017

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0245-2015
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0245-2015. Report a data issue: hello@regdatalab.com.